{"disease":{"id":"midgut-neuroendocrine-tumours","name":"midgut neuroendocrine tumours"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02651987","title":"Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Ipsen","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}